In this seminar, David will cover the essential elements for successful clinical trial strategy, design and execution. Key points will include clinical experimental design (type of design, endpoints, patient selection) as well as practical aspects for execution including competitive analysis, Investigator and site selection and recruitment considerations.
•Common experimental designs
•Patient selection issues
•Primary and secondary endpoints
•Standard of care considerations
•Safety aspects and exclusions
•Real world flexibility
Meet your Presenter: Dr David Fuller
David Fuller is currently Chief Medical Officer, Aucentra Therapeutics Oncology and is a Non-Executive Director of the ASX- listed biotech company, AdAlta (ASX: 1AD). He has more than 30 years of R&D experience and has successfully led 4 product approvals and designed and executed multiple Phase I-III clinical trials. Most recently Dr Fuller was the Senior Vice President of Clinical Development in the Oncology Business Unit at Syneos Health Clinical Solutions. Prior to this he was a Director at Linear Clinical Research, Chairman of Dimerix Bioscience, CMO/COO at Trident Clinical Research, CMO at Arana Therapeutics, and Vice-President Clinical at Genzyme Europe.